Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
493.20 | 5,013 Cr | 76.47 | 7.20 | 0.00 | 0.00 | 0.00 | — | ||
25.58 | 1,787 Cr | 59.95 | 3.66 | 0.02 | 8.06 | 10.61 | 3.65 | ||
302.45 | 1,609 Cr | 144.97 | 2.54 | 0.00 | 2.26 | 4.09 | 0.94 | ||
549.05 | 1,281 Cr | 22.98 | 2.62 | 0.00 | 22.63 | 19.42 | 9.98 | ||
180.65 | 994 Cr | 34.66 | 4.09 | 0.00 | 13.74 | 14.03 | 9.76 | ||
566.80 | 824 Cr | 45.30 | 5.25 | 0.00 | 13.22 | 14.71 | 6.63 | ||
422.40 | 733 Cr | 64.95 | 4.26 | 0.00 | 5.88 | 7.65 | 5.02 | ||
| Median: 7 Co. | — | 422.40 | 1,281 Cr | 59.95 | 4.09 | 0.00 | 8.06 | 10.61 | 5.82 |
Bearish
0
Neutral
14
Bullish
0
Bearish
0
Neutral
46
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Bearish
0
Neutral
14
Bullish
0
Bearish
0
Neutral
14
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Healthcare Equipment & Supplies
Medical Equipment & Supplies
4,789 Cr
High Risk
73.1
51.8
2.6
6.9
558.80
347.50
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: Nov 04, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Sahajanand Medical Technologies Ltd (SMT) is currently trading at 471.15 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Sahajanand Medical Technologies Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Sahajanand Medical Technologies Ltd has traded between a low of ₹347.50 and a high of ₹558.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Sahajanand Medical Technologies Ltd has a market capitalization of approximately 4,789.09. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Sahajanand Medical Technologies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 73.05 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 4,789.09 Cr, Sahajanand Medical Technologies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Sahajanand Medical Technologies Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Sahajanand Medical Technologies Ltd is 73.05. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Shareholding Pattern
Invesco Mutual Fund disclosed a 5.0549% holding in Sahajanand Medical Technologies as of October 23, 2026 under SEBI SAST regulations.
Shareholding Pattern
Sahajanand Medical Technologies received Invesco Mutual Fund’s disclosure that its aggregate holding reached 5.0549% of the company’s paid-up share capital as of October 23, 2026.
Earnings Call/Transcript
Sahajanand Medical Technologies will host an earnings call on November 5, 2026, at 6:30 p.m. IST to discuss Q2 FY27 and H1 FY27 financial results.
Board Meeting
Sahajanand Medical Technologies will hold a Board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for Q2 and the half year ended 30 September 2026.
Legal/Regulatory Proceedings
Sahajanand Medical Technologies received a GST summons from DGGI, Mumbai, for verification of accounts related to reimbursements to foreign subsidiaries for clinical trials. The company stated there is no material impact.
Change in Directors/KMP
Sahajanand Medical Technologies appointed Ms. Deepshikha Singhal (ACS-35992) as Company Secretary & Compliance Officer effective 2025-04-01; appointment approved by the Board on 2025-04-16.
